KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Net Cash Flow: 2009-2025

Historic Net Cash Flow for Tenet Healthcare (THC) over the last 17 years, with Q3 2025 value amounting to $350.0 million.

  • Tenet Healthcare's Net Cash Flow fell 7116.97% to $350.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 billion, marking a year-over-year decrease of 13680.92%. This contributed to the annual value of $1.8 billion for FY2024, which is 38405.41% up from last year.
  • Per Tenet Healthcare's latest filing, its Net Cash Flow stood at $350.0 million for Q3 2025, which was down 7116.97% from -$374.0 million recorded in Q2 2025.
  • In the past 5 years, Tenet Healthcare's Net Cash Flow registered a high of $1.3 billion during Q1 2024, and its lowest value of -$1.1 billion during Q4 2024.
  • For the 5-year period, Tenet Healthcare's Net Cash Flow averaged around $27.8 million, with its median value being $53.0 million (2021).
  • The largest annual percentage gain for Tenet Healthcare's Net Cash Flow in the last 5 years was 146195.65% (2024), contrasted with its biggest fall of 71781.61% (2024).
  • Quarter analysis of 5 years shows Tenet Healthcare's Net Cash Flow stood at $72.0 million in 2021, then tumbled by 586.11% to -$350.0 million in 2022, then soared by 149.71% to $174.0 million in 2023, then plummeted by 717.82% to -$1.1 billion in 2024, then surged by 132.56% to $350.0 million in 2025.
  • Its Net Cash Flow stands at $350.0 million for Q3 2025, versus -$374.0 million for Q2 2025 and -$20.0 million for Q1 2025.